Midatech appoints Jim Phillips CEO
This article was originally published in Clinica
Abingdon, UK-based Midatech, a manufacturer of biocompatible gold nanoparticles (GNPs) with applications across several industries (including therapeutics, diagnostics and medical imaging) has named Dr Jim Phillips chief executive officer. Dr Phillips joins the company from UK consumer healthcare firm Healthcare Brands International, where he has been CEO since 2010. Founded in 2000, privately-held Midatech has a pipeline of product candidates in clinical and preclinical development for the treatment of diabetes and a variety of cancers.